SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitor–Mediated Blunting of Blood Volume Redistribution: A Candidate Mechanism for Attenuating Cardiac Filling Pressures and Exercise Intolerance in Heart Failure—How Do the Data Stack up?
Wayne L. Miller Correspondence to: Wayne L. Miller, MD, PhD, Department of Cardiovascular Medicine, Mayo Clinic, 200 1st St SW,
Read more


